Literature DB >> 17205318

A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.

Lynne Dawkins1, Jane H Powell, Robert West, John Powell, Alan Pickering.   

Abstract

RATIONALE: Smokers may show abnormal functioning in prefrontal cortex during acute abstinence, reflecting deficient activity in mesocorticolimbic circuitry. Cognitive correlates of this putatively include impaired response inhibition and other aspects of executive functioning.
OBJECTIVES: To investigate whether inhibitory control and other executive functions in smokers are impaired during acute abstinence relative to post-nicotine.
METHODS: 145 smokers were tested twice after overnight abstinence-once after nicotine and once after placebo lozenges (order counterbalanced, double-blind)-on an antisaccade task, a continuous performance task (CPT), a delayed response spatial working memory task and a verbal fluency test.
RESULTS: Compared with placebo, nicotine was associated with better inhibitory control on the antisaccade task and fewer impulsive responses to filler stimuli (motor errors) on the CPT; at the first assessment only, nicotine also reduced impulsive responses to 'catch' stimuli on the CPT. However, it did not affect CPT response bias (an index of impulsive vs cautious decision-making), spatial working memory, or verbal fluency.
CONCLUSIONS: Smoking abstinence appears to be associated with a difficulty in inhibiting prepotent motor responses, and with nicotine to attenuate this difficulty. However, more 'cognitive' forms of inhibitory control (e.g. decision-making) and the other aspects of executive function tested here appear to be unaffected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205318     DOI: 10.1007/s00213-006-0634-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Effects of abstinence and smoking on information processing in adolescent smokers.

Authors:  M Zack; L Belsito; R Scher; T Eissenberg; W A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

Review 2.  Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association.

Authors:  Donald R Royall; Edward C Lauterbach; Jeffrey L Cummings; Allison Reeve; Teresa A Rummans; Daniel I Kaufer; W Curt LaFrance; C Edward Coffey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

3.  Pharmacokinetics of a nicotine polacrilex lozenge.

Authors:  Jae H Choi; Carolyn M Dresler; Michele R Norton; Kenneth R Strahs
Journal:  Nicotine Tob Res       Date:  2003-10       Impact factor: 4.244

Review 4.  Inhibition and the right inferior frontal cortex.

Authors:  Adam R Aron; Trevor W Robbins; Russell A Poldrack
Journal:  Trends Cogn Sci       Date:  2004-04       Impact factor: 20.229

5.  Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence.

Authors:  Adrianna Mendrek; John Monterosso; Sara L Simon; Murray Jarvik; Arthur Brody; Richard Olmstead; Catherine P Domier; Mark S Cohen; Monique Ernst; Edythe D London
Journal:  Addict Behav       Date:  2005-07-11       Impact factor: 3.913

6.  A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.

Authors:  Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

7.  Acute effects of nicotine on attention and response inhibition.

Authors:  E M Bekker; K B E Böcker; F Van Hunsel; M C van den Berg; J L Kenemans
Journal:  Pharmacol Biochem Behav       Date:  2005-12-19       Impact factor: 3.533

8.  Transdermal nicotine effects on attention.

Authors:  E D Levin; C K Conners; D Silva; S C Hinton; W H Meck; J March; J E Rose
Journal:  Psychopharmacology (Berl)       Date:  1998-11       Impact factor: 4.530

9.  Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation.

Authors:  A Partiot; M Vérin; B Pillon; C Teixeira-Ferreira; Y Agid; B Dubois
Journal:  Neuropsychologia       Date:  1996-07       Impact factor: 3.139

10.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06
View more
  36 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

3.  Postquitting experiences and expectations of adult smokers and their association with subsequent relapse: findings from the International Tobacco Control (ITC) Four Country Survey.

Authors:  Hua-Hie Yong; Ron Borland; Jae Cooper; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-10       Impact factor: 4.244

4.  A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.

Authors:  Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

5.  Effect of varenicline on aspects of inhibitory control in smokers.

Authors:  A J Austin; T Duka; J Rusted; A Jackson
Journal:  Psychopharmacology (Berl)       Date:  2014-03-21       Impact factor: 4.530

6.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

Review 7.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

8.  Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample.

Authors:  Alex P Miller; Ian R Gizer; William A Fleming Iii; Jacqueline M Otto; Joseph D Deak; Jorge S Martins; Bruce D Bartholow
Journal:  Psychiatry Res       Date:  2019-06-18       Impact factor: 3.222

9.  Use of an automated mobile application to assess effects of nicotine withdrawal on verbal fluency: A pilot study.

Authors:  Serguei V S Pakhomov; Wrenda Teeple; Anne M Mills; Michael Kotlyar
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

Review 10.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.